Our PEC2 team has developed specific tools and expertise in the analysis of new biomarkers of cerebro-cardiovascular risk (ADMA, GDF-15, ...), in the direct (Electron Paramagnetic Resonance) and indirect measurement of reactive oxygen nitrogen species (RONS), as well as in the in vivo and ex vivo assessment of cardiovascular function in rodents (echocardiography, isolated perfused heart).
